Sana Biotechnology Files Form 4 on Ownership Changes
Ticker: SANA · Form: 4 · Filed: Apr 8, 2026 · CIK: 0001770121
Sentiment: neutral
Topics: insider-filing, ownership-change
Related Tickers: SANA
TL;DR
Sana Bio (SANA) filed a Form 4 on 4/8/26 for 4/6/26 transactions. Ownership changes reported.
AI Summary
On April 8, 2026, Sana Biotechnology, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The report covers transactions that occurred on April 6, 2026. The filing details are associated with CIK 0001770121 and relate to the company's operations in biological products.
Why It Matters
Form 4 filings are crucial for investors as they disclose insider transactions, providing insights into the confidence or concerns of company executives and major shareholders.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of changes in beneficial ownership and does not inherently indicate new risks for the company.
Key Players & Entities
- Sana Biotechnology, Inc. (company) — Issuer
- 0001770121 (company) — Issuer CIK
- 0001480212-26-000004 (company) — SEC Accession Number
- 2026-04-08 (date) — Filing Date
- 2026-04-06 (date) — Period of Report
- Bishop Hans Edgar (person) — Reporting Person
FAQ
What type of SEC filing is this?
This is a Form 4 - Statement of changes in beneficial ownership of securities.
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-08 at 16:16:24.
What is the CIK for Sana Biotechnology, Inc.?
The CIK for Sana Biotechnology, Inc. is 0001770121.
What is the period of report for this filing?
The period of report is 2026-04-06.
What is the business address of Sana Biotechnology, Inc.?
The business address is 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 8, 2026 by Bishop Hans Edgar regarding Sana Biotechnology, Inc. (SANA). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.